| Literature DB >> 30186774 |
Ivan Best1, Angela Privat-Maldonado1, María Cruz1, Mirko Zimic2, Rachel Bras-Gonçalves3, Jean-Loup Lemesre3, Jorge Arévalo1,2.
Abstract
Clinical manifestations of American Tegumentary Leishmaniasis (ATL) include cutaneous (CL) and mucous forms (ML); however, there are asymptomatic individuals who despite being infected do not present any clinical manifestations. This study characterized the cell-mediated immunity of travelers who lived in the Andean highlands of Cusco, free of leishmaniasis transmission, which eventually visited leishmaniasis endemic in the Amazonian basin and returned home without any clinical signs of the disease. Their immune response was compared with CL and ML patients who acquired the disease during their stage in the same region. Fifty-four human subjects from the highlands of Cusco (Peru), who have visited an endemic area, were enrolled: 28 of them did not show any symptoms, 12 showed CL and 14 showed ML. Ten healthy subjects from a non-endemic area (HS) were included as controls. T-cell proliferation was evaluated using peripheral blood mononuclear cells (PBMC) stimulated for 5 days with a total soluble leishmanial antigen (TSLA) of L. (V.) braziliensis. Th1/Th2/Th17 cytokines were also quantified in the supernatants by a flow cytometry multiplex assay. T-cell proliferation was expressed as stimulation index (SI) and the cut off was fixed at SI >2.47. Fifteen out of 28 subjects did not show any signs of disease (54%); subjects with an SI above the cut off. They were defined as asymptomatic immune responders (AIR). CL and ML patients presented a higher SI than HS and AIR. Among the latter group, the exposure time to Leishmania was clearly associated with the IFN-γ response. Increased levels of this cytokine were observed in individuals who remained <90 days in an endemic area of leishmaniasis. Our results evidenced two sub-populations among asymptomatic individuals, one AIR who did not develop clinical disease manifestations when they were exposed to Leishmania in endemic areas. Exposure time to Leishmania in the wild was associated with the IFN-γ response.Entities:
Keywords: American Tegumentary Leishmaniasis; T cell proliferation; Th1 response; asymptomatic infection; cellular immune response
Mesh:
Substances:
Year: 2018 PMID: 30186774 PMCID: PMC6111704 DOI: 10.3389/fcimb.2018.00289
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Endemic areas of American Tegumentary Leishmaniasis in Peru. Map showing the areas de migration from the highlands of Cusco to the endemic areas of American Tegumentary Leishmaniasis (ATL).
Figure 2T cell proliferation in asymptomatic immune responders. Cut off for the T cell proliferation stimulation index (SI) in individuals exposed to an endemic area of American Tegumentary Leishmaniasis (ATL). Black dotted line limits the cut off.
Epidemiological parameters and immunological markers in cutaneous and mucosal leishmaniasis patients, asymptomatic immune responders and healthy subjects.
| Age in years | 28 (23.5–45.5) | 36 (24.5–43) | 19 (18–29) | 40 (31.5–46.25) | |
| Male gender | 3 (30) | 7 (47) | 12 (100) | 13 (93) | |
| Exposure time in an endemic area | 90 (37–1871) | 180 (120–810) | 378 (158–2051) | 0.8 | |
| Occupation | 7 (47) | 0 (0) | 0 (0) | ||
| Stimulation index (SI) | 1.26 (0.79–1.63) | 4.70 (3.98–5.40) | 78.7 (30.8–178.3) | 24.55 (14.65–71.47) | < |
| IFN-γ (pg/ml) | 3.35 (0–5.63) | 16.10 (0–39.01) | 3233 (1065–4057) | 4451 (2111–8433) | < |
| TNF-α (pg/ml) | 1.3 (0–8.61) | 6.60 (0.50–14.12) | 102.6 (37.8–220.5) | 142.4 (70.5–207.7) | < |
| IL-10 (pg/ml) | 3.7 (0–52.2) | 27 (4.60–52.63) | 53.9 (16.6–140.2) | 77.9 (15.4–119.4) | 0.083 |
| IL-17A (pg/ml) | 0 (0–7.8) | 0 (0–7.20) | 10.87 (4.78–14.98) | 8.1 (0–32.1) | |
| Ratio IFN-γ/IL-10 | 0.02 (0–0.69) | 0.29 (0–0.74) | 30.9 (21.8–74.3) | 56.7 (31.5–133.6) | < |
P-value for the comparison between CL patients and asymptomatic immune responders,
P-value for the comparison between ML patients and asymptomatic immune responders.
Age, exposure time in an endemic area, stimulation index, ratio IFN-γ/IL-10 as well as IFN-γ, TNF-α, IL-10 and IL-17A levels are presented as median (Q1–Q3).
Male gender and occupation is presented as absolute numbers and percentages (between brackets). CL, cutaneous leishmaniasis; ML, mucosal leishmaniasis; Q1–Q3, first quartile–third quartile.
Spearman rank correlations between age, gender, IFN-γ, TNF-α, IL-10, IL-17A, ratio IFN-γ/IL-10, and exposure time in the infection place less or equal -and longer- than 90 days.
| Age | 0.3715 | 0.1728 |
| Gender | −0.0714 | 0.8003 |
| IFN-γ | −0.6866 | |
| TNF-α | −0.3104 | 0.2602 |
| IL-10 | −0.2483 | 0.3722 |
| IL-17A | −0.4536 | 0.0895 |
| Ratio IFN-γ/IL-10 | 0.8189 |
P-value for the comparison between subjects who stayed less or equal than 90 days vs. subjects who stayed longer than 90 days in an endemic area.
Univariate and multivariate comparison between subjects who stayed less or equal than 90 days and subjects who stayed longer than 90 days in an endemic area.
| Age | −0.1139663 | 0.146 | −0.0996245 | 0.164 |
| Gender | −1.885137 | 0.235 | −0.7773731 | 0.591 |
| Exposure time in an endemic area | −0.0004683 | −0.0004088 | 0.083 |